CORVUS PHARMACEUTICALS

Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03 Sep 2024 15:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

30 Aug 2024 08:54:02 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

26 Aug 2024 08:45:13 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

20 Aug 2024 08:45:10 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

19 Aug 2024 08:45:26 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

16 Aug 2024 14:51:52 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

09 Aug 2024 09:13:40 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

08 Aug 2024 11:16:24 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

07 Aug 2024 08:45:01 By NetDania Notify

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results

06 Aug 2024 15:01:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

02 Aug 2024 08:45:18 By NetDania Notify

Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

01 Aug 2024 07:30:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024

31 Jul 2024 07:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

30 Jul 2024 08:55:53 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

29 Jul 2024 11:38:28 By NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

26 Jul 2024 10:47:58 By NetDania Notify

Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases

25 Jul 2024 07:30:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference

30 May 2024 15:02:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

06 May 2024 15:01:00 By Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024

02 May 2024 15:02:00 By Nasdaq GlobeNewswire